🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Migraine in Children

Supraspinal Processing of Sensory Aspects of Pain NCT05814497NA1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Multisensory Task, Graphesthesia, Divided attention Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old NCT04748601Phase 415 sites📍 Birmingham📍 La Jolla📍 Aurora Upsher-Smith Laboratories · Tests: Qudexy XR, Placebo VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders NCT06665867NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Video consultation, Face-to-face consultation nVNS for the Prevention and Treatment of Primary Headache NCT06277063NA1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Transcutaneous auricular vagus nerve stimulation A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine NCT06995729Phase 114 sites📍 Washington D.C.📍 Hinesville📍 Minneapolis Pfizer · Tests: Zavegepant Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial NCT05337033Phase 23 sites📍 Vancouver📍 Halifax📍 Toronto University of Manitoba · Tests: MPL-001 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) NCT05125302Phase 3129 sites📍 Huntsville📍 Saraland📍 Phoenix AbbVie · Tests: Ubrogepant, Placebo-Matching Ubrogepant Randomized Study in Children and Adolescents With Migraine: Acute Treatment NCT04649242Phase 3246 sites📍 Birmingham📍 Scottsdale📍 Tempe Pfizer · Tests: Rimegepant/BHV3000, Matching placebo Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects NCT05156398Phase 393 sites📍 Fort Smith📍 Hawthorne📍 La Mesa Pfizer · Tests: Rimegepant, Placebo Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine NCT04743141Phase 3124 sites📍 Scottsdale📍 Tempe📍 Anaheim Pfizer · Tests: Rimegepant (PF-07899801) A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine NCT05164172Phase 364 sites📍 New Haven📍 Stamford📍 Gainesville H. Lundbeck A/S · Tests: Eptinezumab A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine NCT04965675Phase 379 sites📍 New Haven📍 Stamford📍 Washington D.C. H. Lundbeck A/S · Tests: Eptinezumab, Placebo Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients NCT06309251n/a3 sites📍 Milan📍 Pavia📍 Roma Danone Nutricia SpA Società Benefit · Tests: ketogenic diet (as per clinical practice)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy